Drug companies bring challenge of North Dakota law to federal court

A legal fight over prescription drug pricing in North Dakota is now playing out in federal court, and at the center of it is a fundamental question. Who actually benefits from a program designed to help low-income patients? A new state law aims to protect access to discounted medications through the federal 340B program, but pharmaceutical companies argue the law goes too far and may even be unconstitutional. North Dakota Monitor reporter Mary Steurer talks to Craig Blumenshine, producer and host of Prairie Public’s Main Street, about the lawsuit and a recent court hearing.